Clinical evaluation of midecamycin acetate dry syrup in oral and maxillofacial infections.
スポンサーリンク
概要
- 論文の詳細を見る
Midecamycin acetate dry syrup was administered to 21 patients with oral and maxillofacial infections and the following results were obtained.<BR>1) The overall clinical effectiveness rate was 90.5% on the basis of judgement by the ratio method, and 95.2% as judged by the physicians in charge.<BR>2) No side effects were observed in any cases.<BR>3) A slight increase in BUN was observed in one case, but the value returned to normal without treatment.<BR>4) The overall clinical usefulness rate was found to be 95.2%.<BR>From the above results, it is concluded that Midecamycin acetate dry syrup is a useful antibiotic for the treatment of oral and maxillofacial infections.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果